Openspace Ventures

Openspace Ventures is a Singapore-headquartered Southeast Asian venture firm with one of the longest active track records in the region, supporting high-growth tech platforms across Indonesia, Vietnam, Thailand, the Philippines, and Singapore. The fund writes Seed, Series A, and Series B checks in the $1M to $25M range and has historically taken concentrated positions in category leaders, including digital health and health IT applications. Healthcare relevance includes telemedicine platforms, hospital and clinic SaaS, pharmacy and supply chain software, insurtech with embedded health products, and AI-enabled care navigation. Founders pursuing biotech or MedTech with multi-year regulatory pathways should look at specialist funds. The right founder is a Southeast Asian operator building a market-leading platform with credible unit economics and a path to dominance in at least one large country market, often Indonesia, before expanding regionally. Openspace is not a fund for capital-light experiments or sub-scale niches; the firm underwrites for category dominance. Geographic advantage is real. Openspace has the longest-running operator network across SEA, deep familiarity with the Indonesian regulatory and corporate buyer environment, and an LP base that includes institutional capital and global LPs comfortable with the region. The fund has historically syndicated with Tier-1 global investors at later stages, which de-risks the Series C path. Best entry is a warm intro from a portfolio founder or a regional co-investor such as East Ventures, AC Ventures, Alpha JWC, or Jungle Ventures; cold-pitch conversion is low. Lead the pitch with revenue, cohort retention, and a credible plan for cross-border expansion that respects the operating reality that each SEA market is a distinct sales motion. AI healthcare founders should describe data asset compounding, multi-language model performance, and clinical or operational integration cycles, which in SEA hospitals can run twelve to eighteen months. Caveats: at $1M to $25M, Openspace can lead Series A or co-lead Series B, but the larger checks come with proportional governance expectations. Ask the firm about reserves, prorata behavior in hard rounds, and the playbook for healthcare-specific commercial introductions, since the firm’s portfolio breadth means partner attention is shared. Reference checks with current portfolio CEOs on responsiveness and value beyond capital are particularly worth the time, given the long-tenure relationships the firm runs. Used appropriately, Openspace is one of the more credible long-cycle partners for SEA healthcare and AI founders building toward category leadership.